...
首页> 外文期刊>Annals of Clinical and Laboratory Science: Official Journal of the Association of Clinical Scientists >A Novel Hemoglobin Variant Associated with Congenital Erythrocytosis: Hb Seoul [beta 86(F2)Ala -> Thr] (HBB:c.259G>A)
【24h】

A Novel Hemoglobin Variant Associated with Congenital Erythrocytosis: Hb Seoul [beta 86(F2)Ala -> Thr] (HBB:c.259G>A)

机译:一种与先天性红细胞增多症相关的新型血红蛋白变体:Hb Seoul [β86(F2)Ala - > Thr](HBB:C.259G> A)

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We report the identification of a novel hemoglobin (Hb) variant [beta 86(F2)Ala -> Thr; HBB: c.259G>A], Hb Seoul, causing congenital erythrocytosis due to high oxygen affinity. The patient was a 33-year-old Korean man with isolated erythrocytosis. JAK2 somatic mutations were negative. Direct sequencing analyses revealed that the patient was heterozygous for c.259G>A, while other known causative genes (BPGM, EGLN1, EPAS, EPOR and VHL) had no mutation. beta 86(F2) is a critical residue that affects the oxygen affinity. The novel variant in our patient, Hb Seoul, adds to the previously reported 4 other Hb variants from beta 86(F2) substitutions that cause congenital erythrocytosis.
机译:我们报告了一种新型血红蛋白(HB)变体[β86(F2)ALA - > THR的鉴定; HBB:C.259G> A],Hb首尔,引起先天性红细胞增多,由于高氧亲和力。 患者是一名33岁的韩国人,患有孤立的红细胞增多症。 JAK2体细胞突变是阴性的。 直接测序分析显示患者对C.259G> A的杂合子,而其他已知的致病基因(BPGM,EGLN1,EPA,EPOR和VHL)没有突变。 β86(F2)是影响氧亲和力的关键残留物。 我们患者HB首尔的新型变异,增加了先前报道的来自β86(F2)替代品的其他4个其他HB变体,导致先天性红细胞增多症。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号